Two calcium phosphate cements, one monophasic and the other biphasic, have been used as bone void filler in a sheep model. The cements were injected into a slot defect in the proximal tibia and into a cylindrical defect in the distal femur. In this study, we focused on the resorption pattern of the
Control of crystallinity of hydrated products in a calcium phosphate bone cement
✍ Scribed by Xiupeng Wang; Jiandong Ye; Yingjun Wang; Xianpei Wu; Bo Bai
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 739 KB
- Volume
- 81A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In this study, a calcium phosphate cement (CPC), consisting of partially crystallized calcium phosphate (PCCP), was synthesized. X‐ray diffraction (XRD), Fourier transform infrared spectrometry (FTIR) and scanning electronic microscope (SEM) were used to characterize the cement. The results showed that by changing the ratio of amorphous calcium phosphate (ACP) to PCCP in the cement, hydrated products of controllable crystallinity were obtained. With increase in the relative amount of PCCP, the hydrated products changed gradually from very poor crystallinity with little needle‐like hydroxyapatite (Hap) crystallites to relatively high crystallinity with more needle‐like Hap crystallites; the compressive strength of the cement increased, and the degradation of the cement decreased. The cement was implanted into the tibia tubercle of healthy mature Zelanian white rabbits and the histological specimens were obtained after 4 and 16 weeks of implantation. The result revealed that this bone cement was biocompatible and showed very early osteoconductive properties. Thus, the CPC has potential for use in orthopedic surgery for filling non‐ load‐bearing bone defects. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
📜 SIMILAR VOLUMES
The setting reaction of a calcium phosphate bone cement consisting of a mixture of 63.2 wt % alpha-tertiary calcium phosphate (TCP)[alpha-Ca3(PO4)2], 27.7 wt % dicalcium phosphate (DCP) (CaHPO4), and 9.1 wt % of precipitated hydroxyapatite [(PHA) used as seed material] was investigated. The cement s
Clinical requirements for calcium phosphate bone cements were formulated in terms of the initial setting time, the final setting time, the cohesion time, and the ultimate compressive strength. Two cement formulations were tested. Biocement F was made of a powder containing alpha-tertiary calcium pho
## Abstract The peak temperature reached during the polymerization of a bone cement was reduced by addition of solid __N__‐vinylcarbazole to the powder component. It was also necessary to saturate the liquid component with __N__‐vinylcarbazole to prevent dissolution from the modified powder compone
## Abstract The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation because it avoids second‐site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression
## Abstract The aim of this study was to investigate the physicochemical and biological properties of a newly developed calcium phosphate cement (CPC). The novel cement was compared with two other commercially available CPCs. After mixing the powder and liquid phase, the CPCs were injected as a pas